Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024 at 08:40 AM EDT
AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group's CEO will testify on Capitol Hill.
